A surgeon based in Klamath Falls, Oregon, is being sued for $7 million after allegedly misdiagnosing a patient’s colon cancer and failing to consult a radiologist, the Herald and News reports.

The wave of megamergers involving health insurers could place the greatest pressure on both not-for-profit and for-profit hospitals, according to a report from Moody’s Investors Service, if these new combinations steer patients away from hospital-owned facilities.

The FDA released, "Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health," on April 17 in an effort to enhance programs and processes to assure the safety of medical devices.

The FDA approved the first use of Trace-Ability’s Tracer-QC at Massachusetts General Hospital for testing of an imaging agent used in positron emission tomography (PET)-N-13 ammonia for injection.

As radiologists become increasingly familiar faces on news sites and in police blotters, one Indiana University professor is suggesting the physicians might be prone to law-breaking due to their steep salaries and a professional culture centered around compliance.

President Donald Trump will deliver a speech on April 26 focused on ways to lower prescription drug prices, but the pharmaceutical industry doesn’t expect it to include the more dramatic reforms Trump espoused on the campaign trail.

The American Board of Radiology (ABR) made significant changes to its certification program for diagnostic radiologists in recent years, removing the oral component of the exam and relying on a standardized format with multiple-choice questions. This shift toward psychometric testing has made the certification program less reliable, according to a new analysis published by the Journal of the American College of Radiology, and the ABR should consider working with various stakeholders and education experts to change it.

Amazon has reportedly shelved plans to sell and distribute pharmaceuticals to hospitals and health systems through its Amazon Business unit, a move which analysts said illustrates the difficulty outside companies face in disrupting the existing healthcare supply chain.